3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
26
Prostatic Neoplasms
5
Osteosarcoma
5
Neuroendocrine Tumors
5
Neoplasms
5
Kidney Neoplasms
5
Colorectal Neoplasms
5
Carcinoma, Hepatocellular
5
Neoplasm Metastasis
4
Urinary Bladder Neoplasms
3
Urethral Neoplasms
3
Sarcoma, Ewing
3
Sarcoma
3
Clear-cell metastatic renal cell carcinoma
3
Carcinoma, Transitional Cell
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Medullary
3
Urogenital Neoplasms
2
Ureteral Neoplasms
2
Small Cell Lung Carcinoma
2
Penile Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Central Nervous System Neoplasms
2
Carcinoma
2
Adrenocortical Carcinoma
2
von Hippel-Lindau Disease
1
Wilms Tumor
1
Urachal adenocarcinoma
1
Triple Negative Breast Neoplasms
1
Interventions
olaparib
3
enzalutamide
2
darolutamide
2
Prednisone
2
Prednisolone
2
Pluvicto
2
Docetaxel
2
Androgen Antagonists
2
Abiraterone Acetate
2
testosterone 17 beta-cypionate
1
radium Ra 223 dichloride
1
fludarabine phosphate
1
fludarabine
1
cabazitaxel
1
alovudine
1
abiraterone
1
Standard of Care
1
Radium-223
1
PSMA-617
1
Nivolumab
1
Gonadotropin-Releasing Hormone
1
Cyclophosphamide
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Metastatic Castration-resistant Prostate Cancer
×
cabozantinib
×
90 days
×
Clear all
No trials found.